Evaluating the HER-2 status of breast cancer using mammography radiomics features-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluating the HER-2 status of breast cancer using mammography radiomics features

Published:2019-12 Issue: Volume:121 Page:108718
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Zhou Jing,Tan Hongna,Bai Yan,Li Jie,Lu Qing,Chen Rushi,Zhang Menghuan,Feng Qin,Wang Meiyun

Funder

National Natural Science Foundation of China

Henan Provincial Department of Science and Technology Research Project

Research and Innovation Foundation for Postgraduates of Mudanjiang Medical University

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference26 articles.

1. Breast cancer incidence and mortality in a transitioning Chinese population: current and future trends;Wong;Br. J. Cancer,2015

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

3. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

4. The distinctive nature of HER2-positive breast cancers;Burstein;N. Engl. J. Med.,2005

5. Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients;Dressler;J. Clin. Oncol.,2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding Breast Cancer: Using Radiomics to Non-Invasively Unveil Molecular Subtypes Directly from Mammographic Images;Journal of Imaging;2024-09-04

2. Radiomics analysis of intratumoral and different peritumoral regions from multiparametric MRI for evaluating HER2 status of breast cancer: A comparative study;Heliyon;2024-04

3. DCE-MRI Based Machine Learning Predictor for HER2-Positive Breast Cancer: A Feasibility and Validation Multicenter Study;2024-03-29

4. Prediction of human epidermal growth factor receptor 2 (HER2) status in breast cancer by mammographic radiomics features and clinical characteristics: a multicenter study;European Radiology;2024-01-26

5. Machine learning‐based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results;Cancer Medicine;2024-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3